Meet the future of bioreactors

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Will Patrick, CEO at Culture Biosciences.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Will, covering:

• How time at Google, MIT and Kendall Square led him to build disruptive tools and hardware for the bioprocessing sector
• Creating a cloud-based, real-time data alternative for companies wanting access to bioreactors... without the need for large-scale investment
• Why biotech and biopharma firms are embracing digitization, virtualization, and simulation... but less so at CDMOs
• Raising funds from VCs that understand the need for technological disruption
• How biotechs, biopharma companies, and CDMOs alike can leverage Culture’s proprietary, integrated, and cloud-based single-use reactor platform
• How enhanced data-driven modeling and simulation can save a lot of time and costs in upstream bioprocess development going forward

Will is an entrepreneurial engineer with a background in mechanical engineering, product design, and bioengineering. He develops hardware products at the interface of biology and digital fabrication. He holds 17 patents and has published 4 peer-reviewed journal articles. He currently runs Culture Biosciences, a company building and operating automated bioreactor infrastructure for the biotech industry.

Will graduated from the MIT Media Lab in 2015 where he was a researcher in the Mediated Matter group. His research focuses on 3D printing fluidic systems and their applications in biotechnology and product design.

Previously, he worked at Google[x] as a Rapid Evaluator where he developed and prototyped new projects for the organization. Will was a founding member of the Google[x] UAV delivery project, Project Wing, was an early team member of Project Loon, and also led the launch communications for Project Glass.

Please subscribe, tell your industry colleagues, and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.